Pharmacokinetics of sparfloxacin in healthy volunteers and patients: A review

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue SUPPL. A, 1996, Pages 27-39

  Montay, Guy ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BILIARY EXCRETION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMALE; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; LIVER CIRRHOSIS; MALE; ORAL DRUG ADMINISTRATION; PLASMA CLEARANCE; TIME; URINARY EXCRETION;

EID: 0029896107     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.suppl_a.27     Document Type: Article

References (20)

1. Child, C. G. (1964). The Liver and Portal Hypertension. W. B. Saunders, Philadelphia.
2. Fillastre, J. P., Montay, G., Bruno, R., Etienne, I., Dhib, M., Vivier, N. et al. (1994). Pharmacokinetics of sparfloxacin in patients with renal impairment. Antimicrobial Agents and Chemotherapy 38, 733-7.
3. Gibaldi, M. & Perrier, P. (1982). Pharmacokinetics, 2nd edn. Marcel Dekker Inc., Basle.
4. Griffiths, N. M., Hirst, B. H. & Simmons, N. L. (1993). Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin: a common secretory pathway? Journal of Pharmacology and Experimental Therapeutics 269, 496-502.
5. Johnson, J. H., Cooper, M. A., Andrews, J. M. & Wise, R. (1992). Pharmacokinetics and inflammatory fluid penetration of sparfloxacin. Antimicrobial Agents and Chemotherapy 36, 2444-6.
6. Kinzig, M., Pilz, D., Naber, K. G., Sorgel, F., Schugg, C. & Dehmlow, C. (1992). Unique body fluid penetration of sparfloxacin in man. In Program and Abstracts of the Thirty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, California, 1992. Abstract 431. American Society for Microbiology, Washington, DC.
7. 14C] sparfloxacin in the rat. Arzneimittel-Forshung 41, 747-59.
8. Mignot, A., Douin, M. J., Millerioux, L., Chassard, D., Thebault, J. J., Montay, G. et al. (1990). Effect of aluminum hydroxide antacid on the pharmacokinetics of the new quinolone sparfloxacin. In Program and Abstracts of the Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, 1990. Abstract 1250, p. 294. American Society for Microbiology, Washington, DC.
9. Montay, G., Bruno, R., Vergniol, J. C., Rey, J., Frydman, A., Peeters, P. A. M. et al. (1991). Pharmacokinetics of sparfloxacin after repeated administration in healthy elderly volunteers. In Program and Abstracts of the Thirty-First Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 1991. Abstract 593. American Society for Microbiology, Washington, DC.
10. Montay, G., Bruno, R., Vergniol, J. C., Ebmeier, M., Le Roux, Y., Guimart, C. et al. (1994). Pharmacokinetics of sparfloxacin in humans after single oral administration at doses of 200, 400, 600 and 800 mg. Journal of Clinical Pharmacology 34, 1071-6.
11. Mugnier, P., Taburet, A.M., Wyld, P.J., Nimmo, W.S., Hayes, P., Grange, D. et al. (1994). Pharmacokinetics of sparfloxacin in patients with hepatic failure. In Program and Abstracts of the Thirty-Fourth Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, 1994. Abstract A48, p. 19. American Society for Microbiology, Washington, DC.
12. Nakamura, S., Kurobe, N., Ohue, T., Hashimoto, M. & Shimizu, M. (1990). Pharmacokinetics of a novel quinolone AT-4140 in animals. Antimicrobial Agents and Chemotherapy 34, 89-93.
13. Nakashima, M., Kanamaru, M., Uematsu, T. & Takiguchi, Y. (1991). Phase I study of pyridone carboxylic acid antibacterial agent, sparfloxacin. Rinshou Iyaku 7, 1639-84.
14. Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C. & Williams, R. (1973). Transection of the oesophagus for bleeding oesophageal varices. British Journal of Surgery 60, 646-9.
15. Shimada, J., Nogita, T. & Ishibashi, Y. (1993). Clinical pharmacokinetics of sparfloxacin. Clinical Pharmacokinetics 25, 358-69.
16. Sörgel, F., Naber, K. G., Jaehde, U., Reiter, A., Seelman, R. & Sigl, G. (1989). Gastrointestinal secretion of ciprofloxacin. American Journal of Medicine 87, Suppl. 5A, 63-5.
17. Thebault, J. J., Montay, G., Ebmeier, M., Douin, M. J., Millerioux, L., Chassard, D. et al. (1990). Effect of food on the bioavailability of the new quinolone sparfloxacin. In Program and Abstracts of the Thirtieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Atlanta, 1990. Abstract 1249, p. 294. American Society for Microbiology, Washington, DC.
18. Wise, R. & Honeybourne, D. (1996). A review of the penetration of sparfloxacin into the lower respiratory tract and sinuses. Journal of Antimicrobial Chemotherapy 37, Suppl. A, 57-63.
19. Wittke, R. R., Fabian, W., Leperlier, C., Lecoeur, H. & Sörgel F. (1992). Biliary concentrations of sparfloxacin and its glucuronide in man. In Proceedings of the Fourth International Symposium on New Quinolones, München, Germany. Abstract 96.
20. Yamaguchi, T., Yokogawa, M., Sekine, Y. & Hashimoto, M. (1991). Intestinal absorption characteristics of sparfloxacin. Xenobiotic Metabolism and Disposition 6, 53-9.